The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined prognostic value of post-surgery circulating tumor DNA and tumor-stroma ratio in patients with stage III colon cancer treated with adjuvant chemotherapy.
 
Ingrid Franken
Research Funding - DoMore Diagnostics (Inst)
 
Floor Heilijgers
No Relationships to Disclose
 
Marie-Christine Bakker
Research Funding - DoMore Diagnostics (Inst)
 
Carmen Rubio-Alarcon
No Relationships to Disclose
 
Nerma Crnovrsanin
No Relationships to Disclose
 
Margriet Lemmens
No Relationships to Disclose
 
Pien Delis-van Diemen
No Relationships to Disclose
 
Mark Sausen
Employment - LabCorp
Stock and Other Ownership Interests - LabCorp
 
Gerrit Meijer
Leadership - CRCbioscreen
 
Miriam Koopman
Research Funding - Bayer (Inst); BMS GmbH & Co. KG (Inst); Merck Serono (Inst); Personal Genome Diagnostics (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst)
 
Geraldine Vink
Research Funding - Bayer (Inst); BMS Netherlands (Inst); Delfi Diagnostics (Inst); Lilly (Inst); Merck (Inst); Natera (Inst); Nordic Bioscience (Inst); Personal Genome Diagnostics (Inst); Pierre Fabre (Inst); SERVIER (Inst)
 
Remond Fijneman
Research Funding - Delfi Diagnostics (Inst); Labcorp (Personal Genome Diagnostics) (Inst); Natera (Inst); Solvias (Cergentis) (Inst)
Patents, Royalties, Other Intellectual Property - several patents pending (Inst)
 
Jeanine Roodhart
No Relationships to Disclose
 
Wilma Mesker
No Relationships to Disclose